187 related articles for article (PubMed ID: 38012690)
1. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors.
Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y
Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690
[TBL] [Abstract][Full Text] [Related]
2. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R;
Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871
[TBL] [Abstract][Full Text] [Related]
3. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas.
Fukushima S; Yamashita S; Kobayashi H; Takami H; Fukuoka K; Nakamura T; Yamasaki K; Matsushita Y; Nakamura H; Totoki Y; Kato M; Suzuki T; Mishima K; Yanagisawa T; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Nagane M; Iuchi T; Yoshimoto K; Mizoguchi M; Tamura K; Sakai K; Sugiyama K; Nakada M; Yokogami K; Takeshima H; Kanemura Y; Matsuda M; Matsumura A; Kurozumi K; Ueki K; Nonaka M; Asai A; Kawahara N; Hirose Y; Takayama T; Nakazato Y; Narita Y; Shibata T; Matsutani M; Ushijima T; Nishikawa R; Ichimura K;
Acta Neuropathol; 2017 Mar; 133(3):445-462. PubMed ID: 28078450
[TBL] [Abstract][Full Text] [Related]
5. Novel somatic and germline mutations in intracranial germ cell tumours.
Wang L; Yamaguchi S; Burstein MD; Terashima K; Chang K; Ng HK; Nakamura H; He Z; Doddapaneni H; Lewis L; Wang M; Suzuki T; Nishikawa R; Natsume A; Terasaka S; Dauser R; Whitehead W; Adekunle A; Sun J; Qiao Y; Marth G; Muzny DM; Gibbs RA; Leal SM; Wheeler DA; Lau CC
Nature; 2014 Jul; 511(7508):241-5. PubMed ID: 24896186
[TBL] [Abstract][Full Text] [Related]
6. KRAS Mutation in Pediatric Intracranial Germ Cell Tumors.
Khaiman C; Techavichit P; Poparn H; Chiangthong K; Lauhasurayotin S; Sosothikul D; Shotelersuk K; Nantavithya C; Jakchairoongruang K; Amornfa J; Khongkhaduead E; Santisukwongchote S; Teerapakpinyo C; Shuangshot S
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3179-3185. PubMed ID: 36172682
[TBL] [Abstract][Full Text] [Related]
7. Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium.
Takami H; Fukuoka K; Fukushima S; Nakamura T; Mukasa A; Saito N; Yanagisawa T; Nakamura H; Sugiyama K; Kanamori M; Tominaga T; Maehara T; Nakada M; Kanemura Y; Asai A; Takeshima H; Hirose Y; Iuchi T; Nagane M; Yoshimoto K; Matsumura A; Kurozumi K; Nakase H; Sakai K; Tokuyama T; Shibui S; Nakazato Y; Narita Y; Nishikawa R; Matsutani M; Ichimura K
Neuro Oncol; 2019 Dec; 21(12):1565-1577. PubMed ID: 31420671
[TBL] [Abstract][Full Text] [Related]
8. Histogenesis of intracranial germ cell tumors: primordial germ cell vs. embryonic stem cell.
Burnham EL; Tomita T
Childs Nerv Syst; 2023 Feb; 39(2):359-368. PubMed ID: 36595083
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors.
Huang X; Zhang R; Mao Y; Zhou LF; Zhang C
World J Pediatr; 2016 Aug; 12(3):275-282. PubMed ID: 27351562
[TBL] [Abstract][Full Text] [Related]
10. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas.
Fukushima S; Otsuka A; Suzuki T; Yanagisawa T; Mishima K; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Narita Y; Shibui S; Kato M; Shibata T; Matsutani M; Nishikawa R; Ichimura K;
Acta Neuropathol; 2014; 127(6):911-25. PubMed ID: 24452629
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of central nervous system germ cell tumors.
Liu S; Ren L; Gao X; Hao M; Wang G
Front Oncol; 2022; 12():991484. PubMed ID: 36158643
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization.
Schneider DT; Zahn S; Sievers S; Alemazkour K; Reifenberger G; Wiestler OD; Calaminus G; Göbel U; Perlman EJ
Mod Pathol; 2006 Jun; 19(6):864-73. PubMed ID: 16607373
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
[TBL] [Abstract][Full Text] [Related]
14. [Evolving Exploration of the Pathogenesis of CNS Germ Cell Tumors with Regard to Precision Medicine].
Takami H; Takayanagi S; Tanaka S; Saito N
No Shinkei Geka; 2022 Jan; 50(1):39-50. PubMed ID: 35169085
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric Framework Magnetic Resonance Imaging Assessment of Subtypes of Intracranial Germ Cell Tumors Using Susceptibility Weighted Imaging, Diffusion-Weighted Imaging, and Dynamic Susceptibility-Contrast Perfusion-Weighted Imaging Combined With Conventional Magnetic Resonance Imaging.
Li Y; Wang P; Zhang J; Li J; Chen L; Qiu X
J Magn Reson Imaging; 2022 Oct; 56(4):1232-1242. PubMed ID: 35278008
[TBL] [Abstract][Full Text] [Related]
16. Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions.
Takami H
Curr Oncol Rep; 2022 Jan; 24(1):105-112. PubMed ID: 35059994
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Capability of Cerebrospinal Fluid-Placental Alkaline Phosphatase Value in Intracranial Germ Cell Tumor.
Okamoto M; Yamaguchi S; Ishi Y; Motegi H; Mori T; Hashimoto T; Terashita Y; Hirabayashi S; Sugiyama M; Iguchi A; Cho Y; Manabe A; Houkin K
Oncology; 2021; 99(1):23-31. PubMed ID: 32906115
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of pediatric patients with autism spectrum disorder and other neurodevelopmental disorders and intracranial germ cell tumors.
Liu KX; Sethi RV; Pulsifer MB; D'Gama AM; LaVally B; Ebb DH; Tarbell NJ; Yock TI; MacDonald SM
Pediatr Blood Cancer; 2021 Aug; 68(8):e28935. PubMed ID: 33694260
[TBL] [Abstract][Full Text] [Related]
19. Update on MRI in pediatric intracranial germ cell tumors-The clinical and radiological features.
Yang M; Wang J; Zhang L; Liu J
Front Pediatr; 2023; 11():1141397. PubMed ID: 37215600
[TBL] [Abstract][Full Text] [Related]
20. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
